intravenously with around 5 x 106 CFU. Injection of each of these strains caused 100%/O mortality, in a pattern similar to that observed with strain 3001.
Trichosporon beigelii (formerly T. cutaneum) is widely distributed in nature and colonizes the skin and gastrointestinal tracts of humans. In normal hosts, it causes white piedra, a benign superficial hair shaft infection encountered mostly in tropical and temperate climates (18) . Invasive infection in immunocompromised patients has been reported with increasing frequency (1, 5, 6, 8-10, 13-18, 20-26) . Most cases have occurred in patients with hematologic malignancies or in recipients of artificial hearts or prosthetic valves and, more recently, in patients with human immunodeficiency virus infections (9, 15) . Clinical manifestations of disseminated trichosporonosis include fever, fungemia, pneumonia, funguria, and skin lesions (23) . Almost any organ can be infected. Diagnosis usually relies on identification of the organism from a culture specimen, particularly blood and a skin biopsy, of an immunocompromised patient or on the presence of characteristic histopathologic findings, including arthroconidia, blastoconidia, and hyphal elements in the appropriate clinical setting (23, 25) . The infection is almost always fatal, despite administration of amphotericin B, unless the patient's neutropenia resolves (1) . Progress in the management of this serious infection has been hampered by both the paucity of clinical data and the lack of an animal model. We developed a murine model of disseminated trichosporonosis in which survival time depends upon the size of the infecting inoculum and the presence 107, or 4 x 107 CFU per mouse) of T. beigelii 3001 was inoculated into the lateral tail veins of four groups of 10 normal CF1 mice. An inoculum of 1 x 106 CFU per mouse was injected into the lateral tail veins of one group of 10 mice receiving CA and another group of 10 mice rendered neutropenic by administration of CY. Control animals were injected once intraperitoneally with CY at a dose of 150 mg/kg or given 125 mg of CA per kg subcutaneously daily for 5 days but did not receive an infectious inoculum. The animals were monitored for 30 days after infection, and mortality was recorded daily. Autopsies were performed on animals that died, and cultures of various organ tissues (liver, spleen, kidney, lung, brain, and heart) were obtained on blood agar and Sabouraud dextrose agar plates and incubated at 35°C for 48 h. To confirm the susceptibility of CF1 mice to different strains of T. beigelii, a titrated dose of (5 + 2) x 106 CFU per animal of each of the other nine strains was injected intravenously into groups of 10 mice rendered neutropenic by intraperitoneal administration of 150 mg of CY per kg. These groups of animals were also observed for mortality and were autopsied, and their organ tissues were cultured as described above. All experiments were done in triplicate.
Organ clearance. In a separate series of experiments designed to determine the extent of organ invasion by T. beigelii, three groups of 60 normal mice each were injected intravenously with 1 X 106, 1 X 107, and 2 x 107 CFU of T. beigelii 3001. Another group of 60 mice treated with CY was also injected with 1 x 106 CFU per mouse. On days 1, 3, 6, 10, 12, 15, 18, and 20, five mice per experimental group were selected at random and killed. Because of the shorter survival times of mice that received the largest fungal inoculum (2 x 107 CFU per animal) and of immunosuppressed mice, examination of organ clearance in these two subgroups was possible only on days 6 and 10 after infection, respectively. The kidneys, liver, spleen, lungs, and brain of each of these animals were removed aseptically and transferred into sterile polyethylene bags, where they were homogenized in 5 ml of sterile saline. Samples were removed from each homogenate, serially diluted in 0.9% NaCl, plated onto Sabouraud dextrose agar plates, and incubated at 35°C for 48 h, and growth was verified at 48 h. The colonies were then counted, and the number of CFU per gram of each organ was calculated. To determine the effect of reinduction of neutropenia on outcome, the group of mice pretreated with CY received an additional identical dose of CY on day 6 of infection and underwent necropsy and quantitative cultures of all organs as described above.
Histopathology. Representative formalin-fixed portions of kidney, liver, spleen, lung, heart, and brain tissues obtained from animals at autopsy were stained with (i) hematoxylin and eosin to detect areas of inflammation and (ii) Gomori methenamine silver to search for fungi in all organs of immunosuppressed mice and in organs with abscesses shown by staining with hematoxylin and eosin.
Statistical analysis. All differences in survival related to the inoculum concentrations administered and the presence or absence of immunosuppression were analyzed by the logrank test (12 
a The data shown are from three experiments.
b Expressed as a multiple of 106 CFU per animal injected intravenously.
duration of neutropenia, which is unlikely to be associated with bacterial superinfection. Experimental infection. Infected mice developed systemic illness characterized by change in fur consistency, lethargy, weight loss, and neurologic abnormalities such as paresis and ataxia. Mortality correlated with the size of the inoculum: survival times were significantly shorter in mice infected with 4 x 107 or 2 x 107 CFU than in mice that received 1 x 107 or 1 x 106 CFU (P < 0.01) (Fig. 1) (Fig. 1) . T. beigelii was the only fungal or bacterial pathogen isolated from cultures of infected organs. All control mice that received CY or CA alone without the infectious inoculum survived throughout the observation period. All 10 different strains of T. beigelii caused comparable mortality rates, albeit with some differences in inoculum size (Table 1) . Organ clearance. As previously noted, the survival times of animals injected with larger inocula or immunosuppressed were shorter than those of normal animals injected with smaller inocula (Fig. 1) . Hence, organ clearance could be examined for up to 20 days for animals injected with 1 x 106 or 1 x 107 CFU, for only 10 days for immunosuppressed animals injected with 1 x 106 CFU, and for only 6 days for animals injected with 2 x 107 CFU (Fig. 2) . Quantitative organ cultures showed that during the first 6 days of infection, the organisms had disseminated to various organs, including the kidneys, liver, spleen, lungs, and brain, particularly in animals that were immunosuppressed or injected with the larger inocula. (6) 1 XIO (7) 2X10 (7) I -*- days) (Gomori-methenamine silver staining; magnification, x400).
15, while only the kidneys appeared to harbor persistent infection at day 20. Kidney infection appeared to have worsened on day 10, after an initial period of partial clearing. Comparative studies of organ clearance between normal and immunosuppressed animals inoculated with 1 x 106 CFU demonstrated significantly higher numbers of fungi in the kidneys, livers, and brains of immunosuppressed mice than in those of normal mice (P < 0.001) (Fig. 2) . The fungal burden in the spleens and lungs of mice was substantially smaller than in other organs examined. No significant differences in organ clearance of fungi were noted between normal and immunosuppressed animals at the splenic and pulmonary sites, perhaps because of an already smaller fungal burden at these sites. Following the second dose of CY, there was a substantial increase in the number of CFU per gram of liver (7 x 104 CFU/g), which was much higher than the initial peak achieved immediately after injection of the fungal inoculum (5 x 103 CFU/g) or the liver fungal burden observed immediately preceding the second CY dose (2 x 103 CFU/g). However, the effect of the second CY dose on the kidneys was modest (an increase from 5 x 105 to 1 x 106 CFU/g) and that on the brain was minimally negative (a decrease from 4 x 106 to 1 x 106 CFU/g).
Histopathologic findings. In normal and neutropenic mice, conidial and hyphal elements and necrotic material, as determined by staining with hematoxylin and eosin and Gomori-methenamine silver, were found in all major organs of all mice at necropsy; these findings closely resemble those on fatal human trichosporonosis (19) . In organs of normal mice and in those of neutropenic mice recovering from myelosuppression, a pyogranulomatous reaction consisting of macrophages, neutrophils, and lymphoid cells was noted, as well as the presence of vascular invasion and thrombosis. In neutropenic mice, the inflammatory cells, particularly the neutrophils, were markedly diminished (Fig. 3) . Chronic inflammation with fibrosis was found in the kidneys of mice that had survived for longer than 10 days.
DISCUSSION
We established a novel and reproducible murine model of disseminated T. beigelii infection by using 10 different clinical isolates. We demonstrated the importance of both inoculum size and the underlying immune status of the host on the extent of the infection and the survival of infected animals. Resistance to infection was significantly reduced by both CY and CA, suggesting a role for various elements of the immune system in host defense against T. beigelii. Both CA and CY have broad immunosuppressive potential that may affect almost all cellular elements of the immune system. Administration of CA to mice has been associated with severe atrophy of the thymus, spleen, and lymph nodes (4, 19) ; decreases in total leukocyte, monocyte, and lymphocytic counts (2, 3) ; and depression of the phagocytic activity of macrophages (7) . Also, the presence of necrotizing abscesses, consisting mostly of neutrophils and macrophages along with fungal elements, suggests that phagocytosis by these cellular elements plays an important role in the host defense against this infection. Similar histopathologic findings on humans have been noted (25) . It is of note that neutropenia in our model persisted for only 5 days, after which the animals recovered from myelosuppression. However, most animals did not survive past neutrophil recovery. This is likely the result of the large infectious inoculum used, as smaller T. beigelii inocula (1 x 104 CFU per animal) are associated with a higher survival rate, despite similar immunosuppression with CY (unpublished data). A host reaction associated with migration of inflammatory phagocytic cells upon recovery to sites of infection could have contributed to the animal's deterioration and death. The exacerbation of infection following reinduction of neutropenia parallels the clinical finding of recurrent T. beigelii infection in patients following reinstitution of cytotoxic chemotherapy (20, 22) . However, these findings were limited to liver infection in our model, while kidney and brain infections did not appear to be significantly affected. Also, the persistent kidney infection observed in mice and the presence of significant funguria in humans suggest that a kidney nidus could be a source of recurrent infection (10, 13, 23, 25) . Drugs that achieve high concentrations in kidneys and urine may, perhaps, be important in the management of these infections. It is noteworthy that the pattern of mortality among animals injected with similar inocula of different strains of T. beigelii was homogeneous. This fungus appears to be less virulent than Candida albicans in mice.
While no animal model can mimic a human infection, this novel murine model offers similarities, some of which include multiorgan involvement, histopathologic findings, persistent kidney infection, and exacerbation of infection after reinstitution of immunosuppression (1, 8, 22, 25) . Hence, this model may be helpful in understanding the pathogenesis of some aspects of trichosporonosis.
In conclusion, we established a reproducible murine model of T. beigelii infection with 10 clinical strains. Survival time was dependent on fungal inoculum size and presence or absence of immunosuppression. An important role of neutrophils and macrophages in host defense against T. beigelii was also suggested. Potential applications of our animal model include testing of novel antifungal agents, study of the mechanism(s) of disease production, and analysis of the role of the immune system in protecting against trichosporonosis.
